SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-24-000238
Filing Date
2024-02-14
Accepted
2024-02-14 07:30:25
Documents
15
Period of Report
2024-02-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 8-K a53896037.htm   iXBRL 8-K 26766
2 EXHIBIT 99.1 a53896037ex99_1.htm EX-99.1 757469
  Complete submission text file 0001157523-24-000238.txt   959914

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crl-20240214.xsd EX-101.SCH 3857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crl-20240214_lab.xml EX-101.LAB 22547
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crl-20240214_pre.xml EX-101.PRE 16040
16 EXTRACTED XBRL INSTANCE DOCUMENT a53896037_htm.xml XML 4077
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

IRS No.: 061397316 | Fiscal Year End: 1230
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 24632295
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)